CA2071625A1 - Preparation pharmaceutique contenant une substance a action thrombolytique - Google Patents

Preparation pharmaceutique contenant une substance a action thrombolytique

Info

Publication number
CA2071625A1
CA2071625A1 CA2071625A CA2071625A CA2071625A1 CA 2071625 A1 CA2071625 A1 CA 2071625A1 CA 2071625 A CA2071625 A CA 2071625A CA 2071625 A CA2071625 A CA 2071625A CA 2071625 A1 CA2071625 A1 CA 2071625A1
Authority
CA
Canada
Prior art keywords
active substance
pharmaceutical preparation
preparation containing
thrombolytically active
thrombolytically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2071625A
Other languages
English (en)
Other versions
CA2071625C (fr
Inventor
Johann Eibl
Anton Philapitsch
Hans P. Schwarz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter AG
Original Assignee
Johann Eibl
Anton Philapitsch
Hans P. Schwarz
Immuno Aktiengesellschaft
Baxter Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johann Eibl, Anton Philapitsch, Hans P. Schwarz, Immuno Aktiengesellschaft, Baxter Aktiengesellschaft filed Critical Johann Eibl
Publication of CA2071625A1 publication Critical patent/CA2071625A1/fr
Application granted granted Critical
Publication of CA2071625C publication Critical patent/CA2071625C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3153—Streptokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6435—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6459—Plasminogen activators t-plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21068—Tissue plasminogen activator (3.4.21.68), i.e. tPA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
CA002071625A 1991-06-20 1992-06-18 Preparation pharmaceutique contenant une substance a action thrombolytique Expired - Fee Related CA2071625C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0124091A AT402263B (de) 1991-06-20 1991-06-20 Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
ATA1240/91 1991-06-20

Publications (2)

Publication Number Publication Date
CA2071625A1 true CA2071625A1 (fr) 1992-12-21
CA2071625C CA2071625C (fr) 2000-02-22

Family

ID=3509640

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002071625A Expired - Fee Related CA2071625C (fr) 1991-06-20 1992-06-18 Preparation pharmaceutique contenant une substance a action thrombolytique

Country Status (6)

Country Link
US (2) US6403556B1 (fr)
EP (1) EP0519900A1 (fr)
JP (1) JPH05170665A (fr)
AT (1) AT402263B (fr)
AU (1) AU656199B2 (fr)
CA (1) CA2071625C (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
JP2886061B2 (ja) * 1993-10-29 1999-04-26 財団法人化学及血清療法研究所 プロテインｃもしくは活性化プロテインｃの安定化方法及び安定化組成物
DK0733371T3 (da) * 1995-03-21 2002-10-07 Baxter Ag Middel til subkutan administrering af protein C
AT409335B (de) * 1998-11-10 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend einen rezeptor-antagonisten zur behandlung von blutgerinnungsstörungen
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
WO2006014839A2 (fr) * 2004-07-23 2006-02-09 The University Of Rochester La proteine c activee inhibe les effets secondaires de l'activateur de plasminogene dans le cerveau

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0215548B2 (fr) * 1985-06-27 1998-01-07 Zymogenetics, Inc. Expression de protéine C
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
EP0287028B1 (fr) 1987-04-17 1993-07-21 Teijin Limited Méthode pour la séparation de protéine C humaine activée
GB8721951D0 (en) 1987-09-18 1987-10-28 Thrombosis Research Trust Organic compounds
WO1989002747A1 (fr) * 1987-10-05 1989-04-06 The American National Red Cross Composition thrombolytique therapeutique
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
GB8819607D0 (en) 1988-08-17 1988-09-21 Wellcome Found Novel combination

Also Published As

Publication number Publication date
US6403556B1 (en) 2002-06-11
AU656199B2 (en) 1995-01-27
EP0519900A1 (fr) 1992-12-23
AT402263B (de) 1997-03-25
JPH05170665A (ja) 1993-07-09
CA2071625C (fr) 2000-02-22
ATA124091A (de) 1996-08-15
AU1830492A (en) 1992-12-24
US5830467A (en) 1998-11-03

Similar Documents

Publication Publication Date Title
CA2193337A1 (fr) Composes de type 1-phenyl-2-dimethylaminomethylcyclohexan-1-o1, ingredients pharmaceutiques actifs
CA2180816A1 (fr) 6-dimethylaminomethyl-1-phenylcyclohexanes, principes actifs en pharmacie
EP0645136A3 (fr) Préparation pharmaceutique du type: substance physiologiquement active à libération prolongée.
CA2154424A1 (fr) 1-phenyl-3-dimethylaminopropane possedant des proprietes pharmaceutiques
HK1034897A1 (en) A double capsule for the administration of active principles in multiple therapies.
IT1232243B (it) Composizioni farmaceutiche a base di ciclosporine
HUT46514A (en) Herbicides comprising aryl-triazolines and pr0cess for producing the active ingredients
HUP9903613A3 (en) Improvement in the taste of active pharmaceutical ingredients
AU4443893A (en) Peptides capable of inhibiting the activity of HIV protease, their preparation and their use
CA2132369A1 (fr) Emploi d'une quantite efficace de substances actives pour le traitement de la peau mixte
HUT49877A (en) Herbicides comprising heterocyclic alkylenequinoxalinyl oxyphenoxypropionate and process for producing the active ingredients
AU5102990A (en) Fungicidally active preparations
AU3917489A (en) Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides
HU9201254D0 (en) Rapamicine-carbamates and medical preparations containing them as active agents
AU8096591A (en) Composition for solid pharmaceutical preparations containing active vitamins d3 and process for preparation thereof
CA2294448A1 (fr) Preparations pharmaceutiques combinees contenant de l'erythropoietine et de l'hemoglobine modifiee
AU1671799A (en) Medicament preparation in the form of a tablet or pellet for acid-labile active substances
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
AU6856194A (en) Vaginal preparation containing physiologically active peptide
CA2071625A1 (fr) Preparation pharmaceutique contenant une substance a action thrombolytique
AU1691988A (en) Physiologically active agent for agricultural use
CA2107476A1 (fr) Unite d'emballage pharmaceutique contenant des activateurs du plasminogene pour administrations multiples en bolus
HUT56839A (en) Fungicide comprising aminoketal compounds and process for producing the active ingredients
USD295937S (en) Portable receptacle
USD288006S (en) Disposable syringe for storing and administering pharmaceutical preparations

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed